FMA
RGNX icon

FNY Managed Accounts’s Regenxbio RGNX Stock Holding History

FNY Managed Accounts’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$2K Buy
+98
New +$2.85K ﹤0.01% 419
2016
Q4 		– Sell
-1,800
Closed -$25.2K – 224
2016
Q3 		$25.2K Buy
+1,800
New +$19.9K 0.02% 257

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

FNY Managed Accounts's RGNX Position: Q1 2018 in Review

FNY Managed Accounts opened a new position in Regenxbio (RGNX) in Q1 2018: 98 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #419 among its holdings. This is a return to the name: FNY Managed Accounts previously reported a position in RGNX as recently as Q3 2016.

FNY Managed Accounts first reported a position in RGNX in Q3 2016 and has held it in 2 quarters since. The position peaked at $25.2K in Q3 2016. 120 funds tracked by Wall St. Rank hold RGNX as of Q1 2018.

  • FNY Managed Accounts held 98 shares of Regenxbio worth $2K as of Q1 2018.
  • Regenxbio was a new FNY Managed Accounts position in Q1 2018.
  • Regenxbio made up ﹤0.01% of FNY Managed Accounts's portfolio in Q1 2018, its #419 holding.
  • FNY Managed Accounts first reported a position in Regenxbio in Q3 2016 and has held it in 2 quarters since.
  • FNY Managed Accounts's Regenxbio position peaked at $25.2K in Q3 2016.
  • 120 funds tracked by Wall St. Rank held Regenxbio as of Q1 2018.

Based on FNY Managed Accounts's 13F filing for Q1 2018, filed 18 Apr 2018.